Benefits of new COVID-19 booster targeting variants outweigh any potential risks, experts say
The benefits of a new COVID-19 booster that targets omicron variants far outweigh the possible risks, experts say.
Aug 25, 2022
0
25
The benefits of a new COVID-19 booster that targets omicron variants far outweigh the possible risks, experts say.
Aug 25, 2022
0
25
Even though most viruses cause infection directly through mucosal cells, the vast majority of vaccines are administered intramuscularly in a cellular mismatch that doesn't always produce optimum immunity.
A University of Minnesota assistant professor is part of a team that has developed a new way to effectively deliver vaccines through mucosal tissues in the nose that could lead to better protection against pathogens like ...
Aug 10, 2022
0
66
The modern strain of the virus that causes cold sores has been traced back to around 5,000 years ago, with researchers suggesting its spread could have been propelled by the emergence of kissing.
Jul 28, 2022
0
21
Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever. Lassa fever is lethal in humans and nonhuman primates with ...
Jul 19, 2022
0
117
Neuroscientists have gained new insight into how our brain evolved into a language-ready brain. Compared to chimpanzee brains, the pattern of connections of language areas in our brain has expanded more than previously thought. ...
Jul 5, 2022
0
250
Scientists at the University of Illinois Chicago have analyzed gene expression data from more than 35,000 blood vessel cells from the lungs of mice and identified two subtypes.
Jun 14, 2022
0
92
Researchers from the research group Developmental Neurobiology at Ruhr-Universität Bochum around Professor Petra Wahle, in collaboration with partners from Mannheim and Jülich, Germany, and Linz, Austria, and La Laguna, ...
Jun 3, 2022
0
318
Islet cell transplants are a promising treatment that can cure difficult-to-treat type 1 diabetes. The cells, taken from a donor pancreas, provide patients with a sustainable and tightly controlled source of insulin. A major ...
May 13, 2022
0
125
A team of researchers from the French health care company Sanofi, working with the National Institutes of Health and the National Cancer Institute in the U.S., has developed two new vaccines against Epstein-Barr infections. ...